Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow …

C Lundgren, PO Bendahl, M Ekholm, M Fernö… - Breast Cancer …, 2020 - Springer
Abstract Background Tumour-infiltrating lymphocytes (TILs) are of important prognostic and
predictive value in human epidermal growth factor receptor 2-positive (HER2+) breast …

[HTML][HTML] Why is appropriate healthcare inaccessible for many European breast cancer patients?–The EBCC 12 manifesto

F Cardoso, F MacNeill, F Penault-Llorca, A Eniu… - The Breast, 2021 - Elsevier
In Europe, inappropriate reimbursement and funding rules and regulations act as
disincentives to best breast cancer care or, at worst, hinder best care. This problem was the …

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase …

M Toi, S Imoto, T Ishida, Y Ito, H Iwata… - The Lancet …, 2021 - thelancet.com
Background Oral fluoropyrimidines, such as S-1, have been shown to have a role in
controlling disease progression in metastatic breast cancer. We examined adjuvant …

Time trends of neoadjuvant chemotherapy for early breast cancer

F Riedel, AS Hoffmann, M Moderow… - … journal of cancer, 2020 - Wiley Online Library
Neoadjuvant chemotherapy (NACT) in early breast cancer (EBC) enables in vivo sensitivity
testing and less radical surgery as compared to primary surgery and adjuvant chemotherapy …

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications

A Bikiewicz, M Banach, S von Haehling… - ESC Heart …, 2021 - Wiley Online Library
The most common cancer diagnosis in female population is breast cancer, which affects
every year about 2.0 million women worldwide. In recent years, significant progress has …

Axilla lymph node dissection can be safely omitted in patients with 1–2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic …

W Gao, S Lu, Y Zeng, X Chen, K Shen - Breast Cancer Research and …, 2022 - Springer
Purpose This study aimed to evaluate whether axillary lymph node dissection (ALND) can
be omitted in patients with 1–2 positive sentinel lymph nodes (SLNs) who received total …

[HTML][HTML] Prognostic and predictive parameters in breast pathology: a pathologist's primer

KH Allison - Modern Pathology, 2021 - Elsevier
The pathologist's role in the breast cancer treatment team has evolved from rendering a
diagnosis of breast cancer, to providing a growing list of prognostic and predictive …

Analysis of mammograms using artificial intelligence to predict response to neoadjuvant chemotherapy in breast cancer patients: proof of concept

I Skarping, M Larsson, D Förnvik - European Radiology, 2022 - Springer
Objectives In this proof of concept study, a deep learning–based method for automatic
analysis of digital mammograms (DM) as a tool to aid in assessment of neoadjuvant …

Therapeutic choices for genitourinary syndrome of menopause (GSM) in breast cancer survivors: a systematic review and update

L Merlino, G D'Ovidio, V Matys, MG Piccioni… - Pharmaceuticals, 2023 - mdpi.com
(1) Background: Genitourinary syndrome of menopause (GSM) is a medical condition that
can affect breast cancer survivors (BCS). This is a complication that often can occur as a …

Rapid and low-cost liquid biopsy with ATR-FTIR spectroscopy to discriminate the molecular subtypes of breast cancer

NMP de Souza, BH Machado, LV Padoin, D Prá… - Talanta, 2023 - Elsevier
Breast cancer (BC) is the most prevalent cancer worldwide. The prognosis and survival of
these patients are directly related to the diagnostic stage. Even so, the gold standard …